ESOMEPRAZOLE MAGNESIUM - esomeprazole magnesium capsule, delayed release
Amerisource Bergen
----------
Active ingredient (in each capsule)
*Esomeprazole 20 mg
(Each delayed-release capsule corresponds to 21.75 mg esomeprazole magnesium dihydrate USP)
Allergy alert:
■ Do not use if you are allergic to esomeprazole.
■ Esomeprazole may cause severe skin reactions.
Symptoms may include: ■ Skin reddening ■ blisters ■ rash. If an allergic reaction occurs, stop use and seek medical help right away.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
Other information
colloidal silicon dioxide, FD&C blue no.1, gelatin, hydroxypropyl cellulose, hypromellose, magnesium carbonate, magnesium oxide, methacrylic acid and ethyl acrylate copolymer dispersion, mono and di glycerides, polysorbate 80, propylene glycol, shellac, sodium lauryl sulfate, strong ammonia solution, sugar spheres (which contains liquid glucose, starch (maize) and sucrose), talc, titanium dioxide, triethyl citrate and yellow iron oxide.
Questions or comments?
call 1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
Distributed By
AmerisourceBergen
1 West First Avenue
Conshohocken, PA 19428
Questions or Concerns?
www.mygnp.com
Made in India
Code: TS/DRUGS/22/2009
Rx
GOOD
NEIGHBOR
PHARMACY®
NDC 46122-736-74
24HR
Esomeprazole Magnesium
delayed-release capsules USP 20 mg*
Acid Reducer
Treats Frequent Heartburn Capsules
May take 1 to 4 days for full effect
14 Capsules One 14-day course of treatment
Rx
GOOD
NEIGHBOR
PHARMACY®
Compare to Nexium® 24HR
active ingredient**
NDC 46122-736-74
See new warning information 24HR
Esomeprazole Magnesium
delayed-release capsules USP 20 mg*
Acid Reducer
Treats Frequent Heartburn
May take 1 to 4 days for full effect
Capsules actual
size
14
Capsules One 14-day course of treatment
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium capsule, delayed release |
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Amerisource Bergen (007914906) |
Registrant - Aurohealth LLC (078728447) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aurobindo Pharma Limited | 650381903 | ANALYSIS(46122-736) , MANUFACTURE(46122-736) |